ACRIVON THERAPE (ACRV)
$5.45
0.00 (0.00%)
ACRV Stock Quote Delayed 30 Minutes
ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q2 2024
ACRV stock results show that Acrivon Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$5.29
Market Cap
169.69M
PE Ratio
-2.11
EPS
-2.5839
Volume (Avg. Vol.)
17,984
Day's Range
$5.21 - $5.54
52-Week Range
$4.69 - $11.90
Dividend & Yield
N/A (N/A)
